Difencloxazine is a tranquilizing agent.

Fosfosal (2-phosphonoxybenzoic acid) is a O-phosphorylated derivative of salicylic acid used in analgesic and anti-inflammatory therapy. Fosfosal showed analgesic effect in the acetic acid-induced writhing and in the hot plate tests in mice, and showed antiinflammatory effect in the xylene induced mice ears swelling and in acetic acid induced increased vascular permeability tests in mice. Both the effects had no significant differences between fosfosal and aspirin, but the former had less stomach irritation.

ISOFEZOLAC is a non-steroid anti-inflammatory drug, prostaglandin synthetase inhibitor. It is indicated for use in various forms of rheumatoid arthritis and osteoarthritis.

Bifeprunox, code name DU-127,090 is an atypical antipsychotic agent, which combines minimal D2 receptor agonism with 5-HT receptor agonism. Bifeprunox was in phase III of clinical trials for the treatment of schizophrenia, Bipolar Depression and in phase I for Parkinson's disease, but these studies were discontinued because efficacy data did not support pursuing the existing development strategy of stabilization of non-acute patients with schizophrenia.

Acetorphine is a synthetic narcotic analgesic. Acetorphine was reported to have uses in veterinary medicine with pronounced advantages in the immobilization of the giraffe in which toxic effects were reduced as compared to the effects of etorphine. In July 1966, the Director-General of the World Health Organization informed the Secretary-General that WHO had arrived at the conclusion that etorphine and acetorphine should be included in Schedule I of the Convention, since they could give rise to similar abuse, and produce similar ill effects as the substances already listed therein. Acetorphine is a Schedule I controlled substance in the United States.

Dulozafone is an anticonvulsant and anxiolytic agent. Dulozafone was derived from glycine. Neuro-pharmacological experiments had demonstrated that dulozafone shows the same pharmacological activity as benzodiazepines and a good in vivo affinity for the benzodiazepine receptor. Dulozafone is a pro-drug, metabolized in vivo to an active form. One of its putative metabolites could be ortho-chloro-diazepam, which is pharmacologically active. Dulozafone had the same anticonvulsant effect on kindled seizures as diazepam. It is potent inhibitor of convulsions and epileptic discharges of fully kindled rats. Dulozafone exerts their anticonvulsant properties in inhibiting the propagation of the epileptic discharge from amygdala to other cerebral structures, particularly those implicated in the motor generalization, such as the substantia nigra.

Duometacin is indomethacin derivative. It was developed as analgesic and anti-inflammatory agent.

Bromamid is derivative of parabromometanitrobenzoic acid with antiseptic and analgesic activity developed by Chugai Pharmaceutical

Brofezil (ICI 54594) is an ibuprofen derivative with anti-inflammatory and analgesic activity.

Diclometide is the antipsychotic agent.